Krajina: Južná Afrika
Jazyk: angličtina
Zdroj: South African Health Products Regulatory Authority (SAHPRA)
Knoll
BRUFEN 200 : Tablets BRUFEN 400 : Tablets BRUFEN 600 : Tablets BRUFEN PAEDIATRIC SUSPENSION : Liquid for oral administration SCHEDULING STATUS Schedule 3 When specifically intended for the treatment of inflammatory joint diseases. Schedule 2 a. Where the recommended daily dose for adults does not exceed 1.2 g and that for children up to and including the age of 12 years does not exceed 20 mg/kg of bodyweight. b. When intended for emergency treatment of acute gout attacks. c. When intended for the treatment of post traumatic conditions such as pain, swelling and inflammation, for a maximum period of 5 days. PROPRIETARY NAME (and dosage form) BRUFEN 200 : Tablets BRUFEN 400 : Tablets BRUFEN 600 : Tablets BRUFEN PAEDIATRIC SUSPENSION : Liquid for oral administration COMPOSITION 200 mg Tablet : Each sugarcoated tablet contains 200 mg ibuprofen 400 mg Tablet : Each sugarcoated tablet contains 400 mg ibuprofen 600 mg Tablet : Each filmcoated tablet contains 600 mg ibuprofen Paediatric Suspension (100 mg/5 mL) : Each 5 mL of suspension contains 100 mg ibuprofen with methyl hydroxybenzoate 0,1% m/v, propyl hydroxybenzoate 0,05% m/v and sodium benzoate 0,25% m/v as preservatives. PHARMACOLOGICAL CLASSIFICATION A/3.1/Antirheumatics (anti-inflammatory agents) PHARMACOLOGICAL ACTION Chemically, ibuprofen is described as 2-(4-isobutylphenyl)propionic acid and is a non-steroidal compound, which exhibits anti-inflammatory, analgesic and antipyretic activities. Brufen is well absorbed on oral administration. An oral dose taken on an empty stomach by human volunteers produ Prečítajte si celý dokument